- 1. (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene Methanamine
- [A synthetic allylamine derivative with antifungal activity. Terbinafine exerts its effect through inhibition of squalene epoxidase, thereby blocking the biosynthesis of ergosterol, an important component of fungal cell membranes. As a result, this agent disrupts fungal cell membrane synthesis and inhibits fungal growth. ( NCI )] (UMLS (NCI) C0076110) =Organic Chemical; Pharmacologic Substance =[AM700] ANTIFUNGALS;
naphthalene;
[DE102] ANTIFUNGAL, TOPICAL;
=(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine Hydrochloride | - 51. ENCEPHALOPATHY NEC
- [ ] (UMLS (ICD9CM) C1260408) Other encephalopathy =Disease or Syndrome
|
- 2. (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine Hydrochloride
- [A synthetic allylamine derivative structurally related to naftifine, antifungal Terbinafine Hydrochloride blocks ergosterol biosynthesis by inhibition of squalene epoxidase, part of the sterol synthesis pathway for the fungal cell membrane. Highly lipophilic, it tends to accumulate in skin, nails, and fatty tissues. Terbinafine is active against dermatophytes. (NCI04) ( NCI )] (UMLS (NCI) C0771029) Terbinafine Hydrochloride;
TERBINAFINE HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene Methanamine;
=TERBINAFINE HYDROCHLORIDE 1 %;
TERBINAFINE HYDROCHLORIDE 250 MG | - 52. Encephalotrigeminal Syndrome
- [A non-inherited congenital condition with vascular and neurological abnormalities. It is characterized by facial vascular nevi (PORT-WINE STAIN), and capillary angiomatosis of intracranial membranes (MENINGES; CHOROID). Neurological features include EPILEPSY; cognitive deficits; GLAUCOMA; and visual defects. ( MSH )] (UMLS (NCI) C0038505) =Congenital Abnormality; Disease or Syndrome =Angiomatosis;
angioma;
Familiar Neoplastic Syndrome;
Neurocutaneous Syndromes |
- 3. (E)-N-methyl-N-(1-naphthylmethyl)-3-phenyl-2-propen-1-amine-hydrochloride
- [The hydrochloride salt form of naftifine, an allylamine derivate with synthetic broad-spectrum antifungal activity. Although the exact mechanism through which naftifine hydrochloride exerts its effect is unknown, it appears to selectively inhibit the enzyme squalene 2,3-epoxidase, thereby inhibiting the biosynthesis of sterol. This results in a decreased amount of sterols, especially ergosterol which is the primary fungal membrane sterol, and a corresponding accumulation of squalene in fungal cells. Naftifine hydrochloride can be fungicidal as well as fungistatic to yeasts depending on the concentration and the organisms involved. ( NCI )] (UMLS (NCI) C0304594) =Organic Chemical; Pharmacologic Substance =naftifin;
=NAFTIFINE HYDROCHLORIDE 1 % | - 53. Enchondromatosis
- [A rare benign disorder characterized by lack of normal endchondral ossification, and the growth of multiple enchondromas. It primarily affects the bones of the hand, in children and young adults. Extent of the disease varies; in some cases, neoplastic involvement may be wide spread causing considerable deformity. ( NCI )] (UMLS (NCI) C0014084) =Congenital Abnormality; Disease or Syndrome =Osteochondrodysplasias;
|
- 4. (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
- [N-(4-hydroxy-3-methoxyphenylmethyl) -8-methyl-6-nonenamide; chili pepper extract and neuropeptide releasing agent selective for primary sensory peripheral neurons, used to experimentally manipulate substance P and other tachykinins, and as an analgesic for Herpes zoster infection. ( CSP )] (UMLS (NCI) C0006931) =Lipid; Pharmacologic Substance =Fatty Acids, Monounsaturated;
Solanaceous Alkaloids;
neuropharmacologic agent;
phenylamide;
[DE650] ANALGESICS, TOPICAL;
=CAPSAICIN 0.075 %;
CAPSAICIN 0.025 %;
CAPSAICIN 0.75 %;
CAPSAICIN 0.25 %;
| - 54. Enclomifene
- [The trans-isomer of clomiphene citrate (CC). Enclomiphene has a higher rate of clearance and is less active than the cis-isomer, cis-clomiphene. Clomiphene citrate has been evaluated for antineoplastic activity against breast cancer. (NCI04) ( NCI )] (UMLS (NCI) C0086213) =Organic Chemical; Pharmacologic Substance ;
|
- 5. *Entitic
- (UMLS (HL7) C1304535) =Quantitative Concept =Kind of quantity;
| - 55. ENCLOMIPHENE CITRATE
- [The citrate salt form of enclomiphene, the cis-isomer of clomiphene, a non-steroidal anti-estrogen compound, with anti-infertility and ovulation stimulating properties. Enclomiphene, behaves similar to estrogen, indirectly blocks hypothalamic estrogen receptors, thereby signalling a lack of estrogen to the hypothalamus and inducing a change in pattern of pulsatile release of gonadotropin-releasing hormone (GnRH), which regulates the discharge of follicle-stimulating hormone (FSH) and luteinizing hormone from the anterior pituitary. As a result, enclomiphene disrupts the cycle of pulsatile release of GnRH thereby leading to ovulation. ( NCI )] (UMLS (NCI) C0086214) =Organic Chemical; Pharmacologic Substance
|
- 6. *Entitic Catalytic Activity
- (UMLS (HL7) C1264686) =Quantitative Concept =Kind of quantity;
| - 56. ENCNTR OCCUPATNAL THRPY
- [ ] (UMLS (ICD9CM) C1971612) Encounter for occupational therapy;
=Finding |
- 7. *Entitic Number
- (UMLS (HL7) C1264689) =Quantitative Concept =Kind of quantity;
| - 57. ENCNTR PLND PO WND CLSR
- [ ] (UMLS (ICD9CM) C0375867) =Finding
|
- 8. *Entitic Substance of Amount
- (UMLS (HL7) C1264685) =Quantitative Concept =Kind of quantity;
| - 58. ENCNTR VOCATIONAL THRPY
- [ ] (UMLS (ICD9CM) C0375866) =Finding
|
- 9. *Entitic Volume
- (UMLS (HL7) C1264690) =Quantitative Concept =Kind of quantity;
| - 59. Encoded Data
- (UMLS (HL7) C1552665) =Idea or Concept =Binary Data;
=Character;
|
- 10. ENA-78
- [Epithelial neutrophil activating peptide-78. A 78 amino acid member of the CXC family of chemokines, produced and secreted upon stimulation by interleukin 1 beta or tumor necrosis factor alpha. Stimulates chemotactic migration of neutrophils, monocytes, lymphocytes, and fibroblasts. ( NCI )] (UMLS (NCI) C1510510) Lipopolysaccharide-Induced CXC Chemokine;
LIX;
Recombinant ENA-78;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance | - 60. Encoding
- (UMLS (HL7) C1547699) =Idea or Concept ;
=HL7 Vocabulary Version 2.5;
=No encoding - data are displayable ASCII characters.;
Encoding as defined by MIME (Multipurpose Internet Mail Extensions) standard RFC 1521. Four consecutive ASCII characters represent three consecutive octets of binary data. Base64 utilizes a 65-character subset of US-ASCII, consisting of both the upper and;
Hexadecimal encoding - consecutive pairs of hexadecimal digits represent consecutive single octets.;
|
- 11. Enable Sending Events
- (UMLS (HL7) C1550019) =Idea or Concept =Remote control command;
| - 61. Encoding as defined by MIME (Multipurpose Internet Mail Extensions) standard RFC 1521. Four consecutive ASCII characters represent three consecutive octets of binary data. Base64 utilizes a 65-character subset of US-ASCII, consisting of both the upper and
- (UMLS (HL7) C1548515) =Idea or Concept =Encoding;
|
- 12. Enacard
- (UMLS (NCI) C0700916) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 62. Encopresis
- [Incontinence of feces not due to organic defect or illness.(MSH)] (UMLS (ICPC) C0014089) (Encopresis; ENKOPRESIA,BESTE GOROTZ INKONTINENTZIA ARAZO BAT; Enkoprese; Encopresis; TUHRIMINEN; Encopresie; Enkopresis; enkoprezis; encopresis; Encopresi; UFRIVILLIG AVFORING/ENKOPRESE f98.1; Encoprese; Encopresis; ENKOPRES) =Finding ;
=Elimination Disorders; gastrointestinal sign/symptom; Symptoms and Complaints Component; PSYCHOLOGICAL |
- 13. ENALAPRIL
- [1-carboxy-3-phenylpropyl-L-alanyl- L-proline (as 1'-ethyl ester, maleate 1:1), is an ACE inhibitor used as an antihypertensive. ( CSP )] (UMLS (NCI) C0014025) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=Amino Acids, Cyclic;
[CV800] ACE INHIBITORS;
dipeptide;
beta antiadrenergic agent =ENALAPRILAT;
ENALAPRIL MALEATE;
ENALAPRILAT;
ENALAPRIL MALEATE | - 63. encounter
- [An interaction between a patient and healthcare participant(s) for the purpose of providing patient service(s) or assessing the health status of a patient. For example, outpatient visit to multiple departments, home health support (including physical therapy), inpatient hospital stay, emergency room visit, field visit (e.g., traffic accident), office visit, occupational therapy, telephone call. ( HL7V3.0 )] (UMLS (HL7) C1554196) =Idea or Concept =act;
|
- 14. Enalapril Maleate/Hydrochlorothiazide
- [A combination preparation of a synthetic angiotensin-converting enzyme (ACE) inhibitor prodrug and a diuretic thiazide, with antihypertensive activity. Enalapril maleate is de-esterified within the cells into its active form enalaprilat that inhibits ACE, thereby prevents the formation of angiotensin II, and blocks angiotensin II mediated activities, including vasoconstriction and stimulation of aldosterone synthesis and secretion, which regulates extracellular sodium concentration. Hydrochlorothiazide inhibits electrolytes reabsorption via binding to Na-Cl cotransporter on the renal distal tubular, thereby increasing excretion of sodium, potassium, chloride, bicarbonate and water. Both agents lead to a reduction in blood pressure. ( NCI )] (UMLS (NCI) C1302042) =Organic Chemical; Pharmacologic Substance ;
| - 64. Encounter Acuity
- [The level of resource intensiveness of patient care. ( HL7V3.0 )] (UMLS (HL7) C1553717) =Intellectual Product =CodeSystem;
|
- 15. ENALAPRILAT
- [The active metabolite of the pro-drug enalapril, a dicarboxylate-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Enalaprilat prevents the conversion of angiotensin I into angiotensin II by inhibiting ACE, thereby leading to decreased vasopressor activity and resulting in vasodilation. This agent also decreases aldosterone secretion by the adrenal cortex, which leads to an increase in natriuresis. ( NCI )] (UMLS (NCI) C0014027) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=ENALAPRIL;
=ENALAPRILAT 1.25 MG/ML;
| - 65. Encounter for adequacy testing for dialysis
- [ ] (UMLS (ICD9CM) C0878730) =Finding
|
- 16. Enamel
- [hard, thin, translucent layer of calcified substance that envelops and protects the dentin of the crown of the tooth, almost entirely composed of calcium salts. ( CSP )] (UMLS (NCI) C0011350) =Body Substance ;
=dental structure;
=enamel organ;
amelogenin;
enamelin;
| - 66. Encounter for adequacy testing for hemodialysis
- [ ] (UMLS (ICD9CM) C0878731) HEMODIALYSIS TESTING =Finding
|
- 17. Enamel Formation
- (UMLS (NCI) C1333380) =Finding
| - 67. Encounter for adequacy testing for peritoneal dialysis
- [ ] (UMLS (ICD9CM) C0878732) PERITONEAL DIALYSIS TEST =Finding
|
- 18. enamel organ
- [epithelial cells surrounding the dental papilla and differentiated into three layers: the inner enamel epithelium, consisting of ameloblasts which eventually form the enamel, and the enamel pulp and external enamel epithelium, both of which atrophy and disappear before and upon eruption of the tooth, respectively. ( CSP )] (UMLS (CSP) C0014032) =Tissue =Enamel;
| - 68. Encounter for antenatal screening of mother
- [ ] (UMLS (ICD9CM) C1719685) =Finding
|
- 19. enamelin
- [protein that is part of the dental enamel matrix and functions in dental development. ( CSP )] (UMLS (CSP) C0059090) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Enamel;
Extracellular Matrix Protein | - 69. Encounter for antineoplastic chemotherapy and immunotherapy
- [ ] (UMLS (ICD9CM) C0476658) =Finding
|
- 20. Enanthoic Acid
- [An aliphatic carboxylic acid, also known as enanthic acid, used in the synthesis of esters for products such as fragrances and artificial flavor preparations. ( NCI )] (UMLS (NCI) C0443770) =Lipid ;
| - 70. Encounter for antineoplastic immunotherapy
- [ ] (UMLS (ICD9CM) C1561678) IMMUNOTHERAPY ENCOUNTER;
=Finding |
- 21. enantiomer
- [ ] (UMLS (CSP) C0599473) =Chemical Viewed Structurally
| - 71. Encounter for dialysis and dialysis catheter care
- [ ] (UMLS (ICD9CM) C0375864) =Finding
|
- 22. Enanton
- (UMLS (NCI) C0524775) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine; Hormone
| - 72. Encounter for extracorporeal dialysis
- [ ] (UMLS (ICD9CM) C0260771) =Finding
|
- 23. ENCAINIDE
- [One of the ANTI-ARRHYTHMIA AGENTS, it blocks SODIUM CHANNELS and slows conduction within the His-Purkinje system and myocardium. ( MSH )] (UMLS (NCI) C0085251) =Organic Chemical; Pharmacologic Substance ;
=Anilides;
[CV300] ANTIARRHYTHMICS =ENCAINIDE HYDROCHLORIDE | - 73. Encounter for fitting and adjustment of non-vascular catheter NEC
- [ ] (UMLS (ICD9CM) C0375874) =Finding
|
- 24. encapsulated
- [(en-KAP-soo-lay-ted) Confined to a specific, localized area and surrounded by a thin layer of tissue. ( NCI )] (UMLS (NCI) C0205223) =Qualitative Concept
| - 74. Encounter for fitting and adjustment of vascular catheter
- [ ] (UMLS (ICD9CM) C0375873) =Finding
|
- 25. Encapsulated data
- (UMLS (HL7) C1547353) =Idea or Concept =Data type;
| - 75. Encounter for general counseling and advice on contraceptive management
- [ ] (UMLS (ICD9CM) C0375816) =Finding
|
- 26. Encapsulated Data
- (UMLS (HL7) C1548310) =Idea or Concept =Value type;
| - 76. Encounter for general counseling on initiation of other contraceptive measures
- [ ] (UMLS (ICD9CM) C0375818) =Finding
|
- 27. Encapsulated Mass
- (UMLS (NCI) C1333381) =Finding
| - 77. Encounter for general counseling on prescription of oral contraceptives
- [ ] (UMLS (ICD9CM) C0375817) =Finding
|
- 28. Encapsulated Neoplasm
- (UMLS (NCI) C1444066) =Finding ;
| - 78. Encounter for hearing conservation and treatment
- [ ] (UMLS (ICD9CM) C1955615) HEARING CONSERVATN/TRTMT;
=Disease or Syndrome |
- 29. Encapsulated Thymoma
- [A thymoma that is confined within the capsule and may display benign or malignant morphologic characteristics. —2003 ( NCI )] (UMLS (NCI) C1333383) =Neoplastic Process
| - 79. Encounter for hearing examination following failed hearing screening
- [ ] (UMLS (ICD9CM) C1719698) HEARING EXAM-FAIL SCREEN =Finding
|
- 30. ENCEPH & ENCEPHLALO NEC
- [ ] (UMLS (ICD9CM) C1719365) Other causes of encephalitis and encephalomyelitis =Disease or Syndrome ;
| - 80. Encounter for insertion of implantable subdermal contraceptive
- [ ] (UMLS (ICD9CM) C0375829) =Finding
|
- 31. ENCEPH/ENCEPHMYE OTH DIS
- [ ] (UMLS (ICD9CM) C1719346) Encephalitis and encephalomyelitis in viral diseases classified elsewhere =Disease or Syndrome
| - 81. Encounter for insertion of intrauterine contraceptive device
- [ ] (UMLS (ICD9CM) C0375820) =Finding
|
- 32. ENCEPH/MYEL FOLWG IMMUNE
- [ ] (UMLS (ICD9CM) C1719353) Encephalitis and encephalomyelitis following immunization procedures =Pathologic Function ;
| - 82. Encounter for insulin pump training
- (UMLS (ICD9CM) C1260472) INSULIN PUMP TRAINING =Therapeutic or Preventive Procedure
|
- 33. ENCEPH/MYELITIS-OTH INF
- [ ] (UMLS (ICD9CM) C1719350) Other encephalitis and encephalomyelitis due to infection classified elsewhere =Disease or Syndrome
| - 83. Encounter for lengthening/adjustment of growth rod
- [ ] (UMLS (ICD9CM) C1260462) LENGTH/ADJUST GROWTH ROD =Therapeutic or Preventive Procedure
|
- 34. encephalitis
- [inflammation of the brain due to infection, autoimmune processes, toxins, and other conditions; viral infections are a relatively frequent cause of this condition. ( CSP )] (UMLS (CSP) C0014038) =Disease or Syndrome ;
=Brain Diseases;
Central Nervous System Viral Diseases =telencephalic leukoencephalopathy;
encephalomyelitis;
Meningoencephalitis;
Encephalitis, Viral;
Limbic Encephalitis;
| - 84. Encounter for long-term (current) drug use
- [ ] (UMLS (ICD9CM) C0375869) =Finding
|
- 35. Encephalitis Lethargica
- (UMLS (NCI) C0014040) =Disease or Syndrome ;
| - 85. Encounter for long-term (current) use of antibiotics
- [ ] (UMLS (ICD9CM) C1955605) LONG-TERM USE ANTIBIOTIC;
=Finding |
- 36. ENCEPHALITIS NOS
- [ ] (UMLS (ICD9CM) C1719369) Unspecified cause of encephalitis, myelitis, and encephalomyelitis =Finding ;
| - 86. Encounter for long-term (current) use of anticoagulants
- [ ] (UMLS (ICD9CM) C0375870) =Finding
|
- 37. encephalitis virus
- [collection of single stranded RNA viruses scattered across the Bunyaviridae, Flaviviridae, and Togaviridae families whose common property is the ability to induce encephalitic conditions in infected hosts. ( CSP )] (UMLS (CSP) C0014051) =Virus ;
=RNA virus;
neurotropic virus | - 87. Encounter for long-term (current) use of antiplatelets/antithrombotics
- [ ] (UMLS (ICD9CM) C1955607) LNG USE ANTIPLTE/THRMBTC;
=Finding |
- 38. Encephalitis, myelitis, and encephalomyelitis
- (UMLS (ICD9CM) C0014058) =Disease or Syndrome ;
| - 88. Encounter for long-term (current) use of aspirin
- [ ] (UMLS (ICD9CM) C1955609) LONG-TERM USE OF ASPIRIN;
=Finding |
- 39. Encephalitis, myelitis, and encephalomyelitis following immunization procedures
- [ ] (UMLS (ICD9CM) C1719358) =Pathologic Function ;
| - 89. Encounter for long-term (current) use of insulin
- [ ] (UMLS (ICD9CM) C1455979) LONG-TERM USE OF INSULIN;
=Finding |
- 40. Encephalitis, myelitis, and encephalomyelitis in protozoal diseases classified elsewhere
- [ ] (UMLS (ICD9CM) C1719349) PROTOZOAL ENCEPHALITIS =Disease or Syndrome
| - 90. Encounter for long-term (current) use of non-steroidal antiinflammatories (NSAID)
- [ ] (UMLS (ICD9CM) C1955608) LONG-TERM ANTI-INFLAMTRY;
=Finding |
- 41. Encephalitis, myelitis, and encephalomyelitis in rickettsial diseases classified elsewhere
- [ ] (UMLS (ICD9CM) C1719348) RICKETTSIAL ENCEPHALITIS =Disease or Syndrome
| - 91. Encounter for long-term (current) use of other medications
- [ ] (UMLS (ICD9CM) C0375871) =Finding
|
- 42. Encephalitis, myelitis, and encephalomyelitis in viral diseases classified elsewhere
- [ ] (UMLS (ICD9CM) C0477341) =Disease or Syndrome
| - 92. Encounter for long-term (current) use of steroids
- (UMLS (ICD9CM) C1260466) LONG-TERM USE STEROIDS =Finding
|
- 43. ENCEPHALOCELE
- [Cerebral tissue herniation through a congenital or acquired defect in the skull. The majority of congenital encephaloceles occur in the occipital or frontal regions. Clinical features include a protuberant mass that may be pulsatile. The quantity and location of protruding neural tissue determines the type and degree of neurologic deficit. Visual defects, psychomotor developmental delay, and persistent motor deficits frequently occur. ( MSH )] (UMLS (ICD9CM) C0014065) =Congenital Abnormality ;
=neural tube defect;
| - 93. Encounter for menstrual extraction
- [ ] (UMLS (ICD9CM) C0362068) =Finding ;
|
- 44. encephalography
- [examination of the brain by radiography after the withdrawal of cerebrospinal fluid (by lumbar or cisternal puncture) and introduction of air, another gas, or contrast material. ( CSP )] (UMLS (CSP) C0221536) =Diagnostic Procedure ;
=brain imaging/visualization/scanning;
=brain ventriculography;
ultrasound echoencephalography;
EEG;
magnetoencephalography | - 94. Encounter for other and unspecified procedures and aftercare
- [ ] (UMLS (ICD9CM) C0260777) =Finding
|
- 45. encephalomyelitis
- [inflammation of the brain and spinal cord, often used to indicate an infectious process, but also applicable to a variety of autoimmune and toxic-metabolic conditions. ( CSP )] (UMLS (CSP) C0014070) =Disease or Syndrome ;
=Central Nervous System Disease;
encephalitis =autoimmune encephalomyelitis;
Encephalomyelitis, Equine;
Leukoencephalitis, Acute Hemorrhagic;
CFS;
| - 95. Encounter for other specified aftercare
- [ ] (UMLS (ICD9CM) C0375875) =Finding
|
- 46. Encephalomyelitis due to rubella
- (UMLS (ICD9CM) C0033359) =Disease or Syndrome
| - 96. Encounter for other specified aftercare following surgery
- [ ] (UMLS (ICD9CM) C0375868) =Finding
|
- 47. encephalomyelopathy
- [ ] (UMLS (CSP) C0598106) =Disease or Syndrome
| - 97. Encounter for other specified procedures and aftercare
- [ ] (UMLS (ICD9CM) C0375872) =Finding
|
- 48. encephalomyeloradiculoneuritis
- [ ] (UMLS (CSP) C0597755) =Disease or Syndrome ;
| - 98. Encounter for palliative care
- [ ] (UMLS (ICD9CM) C0375892) =Finding
|
- 49. encephalomyocarditis group virus
- [ ] (UMLS (CSP) C0598064) =Virus ;
| - 99. Encounter for Papanicolaou cervical smear to confirm findings of recent normal smear following initial abnormal smear
- [ ] (UMLS (ICD9CM) C1455985) PAP SMEAR CONFIRMATION;
=Finding |
- 50. encephalopathy
- [A disorder of the brain that can be caused by disease, injury, drugs, or chemicals. ( NCI )] (UMLS (NCI) C0085584) =Disease or Syndrome ;
| - 100. Encounter for removal of internal fixation device
- [ ] (UMLS (ICD9CM) C1260461) REMOVAL INT FIXATION DEV =Therapeutic or Preventive Procedure
|
home
